Trial Profile
A Study to Evaluate the Efficacy/Safety of Transdermal Testosterone for 24 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Mar 2010
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Decreased libido; Menopause
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 31 Mar 2010 New trial record